You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

The stress response and critical illness: A review*

Cuesta, Jeronimo M. MD; Singer, Mervyn MD, FRCP, FFICM

Critical Care Medicine:
doi: 10.1097/CCM.0b013e31826567eb
Review Articles
Abstract

Objectives: To describe different paradigms that define the stress response, and to postulate how stress is implicated in the pathophysiology of critical illness.

Design: Articles were identified through a search of PubMed and Google Scholar.

Results: The stress response represents a bundle of adaptive behavioral, physiological, and cellular responses. Although generally beneficial, an important adverse consequence of excessive stress is organ dysfunction. Many interventions currently applied to the critically ill patient are additive and may contribute to organ dysfunction, renewed deterioration, and impaired or delayed recovery. Resilience (ρ) summarizes the interaction among predisposition factors, injury (or stressors), and the body’s allostatic responses. Resilience changes over the course of critical illness but is potentially measurable and may be used to identify at-risk patients and to tailor therapy.

Conclusion: Critical illness may represent a stress-related decompensation syndrome mediated by neural, endocrine, bioenergetic, and immune systems. As patients pass through the separate phases of critical illness, consideration should be given to different therapeutic end points. This may be particularly pertinent during the established organ dysfunction phase where targeting of normal values may have deleterious consequences. Improved strategies could thus emerge from an increased knowledge and monitoring of the stress response, and what constitutes an optimal adaptive state as it evolves in the course of critical illness.

Author Information

From the Department of Intensive Care, North Middlesex University Hospital (JMC); and Division of Medicine, Bloomsbury Institute of Intensive Care Medicine, University College London (MS), London, United Kingdom.

*See also p. 3327.

Dr. Singer works at UCLH/UCL, which receives a proportion of its funding from the UK Department of Health’s NIHR Biomedical Research Centre’s funding scheme.

The authors have not disclosed any potential conflicts of interest.

Address requests for reprints to: Jeronimo M. Cuesta, MD, Department of Intensive Care, North Middlesex University Hospital, Sterling Way N18 1QX, London, United Kingdom. E-mail: Jeronimo.MorenoCuesta@nmh.nhs.uk

© 2012 by the Society of Critical Care Medicine and Lippincott Williams & Wilkins